香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因 依賴該等內容而引致的任何損失承擔任何責任。 Edvantage Group Holdings Limited 中滙集團控股有限公司 （於開曼群島註冊成立的有限公司） （股份代號：0382） 持續關連交易 — 酒店經營合約 於2025年10月31日（交易時段後），華商酒店（本公司的全資附屬公司）與太陽 城大酒店訂立酒店經營合約，據此，太陽城大酒店將承包處所予華商酒店經 營。 由於太陽城大酒店為一家由廖先生及陳女士分別間接擁有50%及50%股權的 公司，故根據《上市規則》第十四A章為本公司的聯繫人及關連人士，因此， 酒店經營合約項下擬進行的交易構成本集團的持續關連交易。 由於酒店經營合約、酒店管理合約及酒店使用協議乃於12個月期間內訂立， 故根據《上市規則》第14A.81條，酒店經營合約、酒店管理合約及酒店使用協 議應合併為單一系列交易。根據《上市規則》第十四A章，就酒店經營合約項 下擬進行的交易而言，無論單獨計算或與酒店管理合約及酒店使用協議項下 擬 ...

Group 1 - The company Zhonghui Group (00382) announced the issuance of 16.2706 million shares as part of a scrip dividend scheme for the interim dividend for the six months ending February 28, 2025 [1]

Core Viewpoint - Zhonghui Group (00382) announced the issuance of 16.2706 million shares as part of a scrip dividend scheme on October 31, 2025, based on the interim dividend for the six months ending February 28, 2025 [1] Summary by Category - **Company Announcement** - Zhonghui Group will issue 16.2706 million shares under the scrip dividend plan [1] - The issuance is scheduled for October 31, 2025 [1] - The shares are related to the interim dividend for the period ending February 28, 2025 [1]

Core Viewpoint - Zhonghui Group (00382.HK) announced a plan to issue 16.2706 million shares as a scrip dividend on October 31, 2025, based on the interim dividend for the six months ending February 28, 2025 [1] Summary by Relevant Sections - **Company Announcement** - Zhonghui Group will issue 16.2706 million shares as part of its scrip dividend plan [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 中滙集團控股有限公司（於開曼群島註冊成立的有限公司） 呈交日期： 2025年10月31日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | | 是 | | | | 證券代號 (如上市) | 00382 | 說明 | | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存 ...

Core Insights - The brain-computer interface (BCI) industry is receiving significant policy support, with various local and national initiatives aimed at promoting innovation and clinical application [1][3][4] Group 1: Company Performance - Several listed companies have announced substantial profit increases for the third quarter, with Guangdong Mingzhu and Limin Co. expected to see net profit growth of over 600% [1] - Guangdong Mingzhu anticipates a net profit of 215 million to 263 million yuan, representing a year-on-year increase of 858.45% to 1071.44% [1] - Limin Co. expects a net profit of 384 million to 394 million yuan, reflecting a growth of 649.71% to 669.25% [1] Group 2: Policy Support for BCI - The East Lake High-tech Zone has introduced measures to support BCI technology development, including funding for R&D and operational support for innovation centers [2] - The measures include a maximum of 30% support for project R&D expenses and up to 50 million yuan in funding [2] - The establishment of the Hubei BCI Industry Innovation Development Alliance aims to accelerate innovation through collaboration among clinical resources, leading enterprises, and research teams [2] Group 3: Market Potential and Growth - The global BCI market is projected to grow from 2.62 billion USD in 2024 to 2.94 billion USD in 2025, with significant potential in the medical field [5] - McKinsey forecasts that the global market for BCI in the medical sector could reach 40 billion USD between 2030 and 2040, with a compound annual growth rate exceeding 10% [5] - Several BCI-related stocks have seen significant price increases, with some doubling in value, indicating strong investor interest [5][6] Group 4: Institutional Research and Investment - Multiple BCI concept stocks have undergone intensive institutional research, with companies like Xiangyu Medical and Zhongke Information receiving multiple inquiries [5][6] - Xiangyu Medical highlighted its integrated product advantages in BCI technology and rehabilitation equipment during recent research discussions [5] - Companies such as Senwo Medical are focusing on BCI as a strategic direction, indicating a broader industry trend towards embracing new technologies [6]

Group 1: Company Earnings Forecasts - Several listed companies announced significant profit increases for the third quarter, with Guangdong Mingzhu (600382) and Limin Co., Ltd. (002734) expecting net profit growth of over 600% [1][2] - Guangdong Mingzhu forecasts a net profit of 215 million to 263 million yuan, representing a year-on-year increase of 858.45% to 1071.44%, primarily driven by its subsidiary's performance [1][2] - Limin Co., Ltd. anticipates a net profit of 384 million to 394 million yuan, reflecting a growth of 649.71% to 669.25%, supported by increased sales and prices of its main products [1][2] Group 2: Brain-Computer Interface (BCI) Policy Support - The Wuhan East Lake High-tech Zone has introduced measures to support the development of the brain-computer interface industry, including funding for key technology research and product development [3][4] - The measures include a maximum of 30% support for R&D expenses and up to 50 million yuan for project investments, as well as annual operational funding for innovation centers [3][4] - The region is also promoting the establishment of an industrial cluster for brain-computer interfaces, with a focus on collaboration between enterprises and research institutions [4] Group 3: National and Local Policy Initiatives - Nationally, policies have been implemented to promote the brain-computer interface industry, including the goal of cultivating 2-3 globally influential companies by 2030 [5][6] - Local governments have also released action plans to support the commercialization of brain-computer interface products across various sectors by 2030 [5][6] - Specific plans from cities like Shanghai and Sichuan outline targets for clinical applications and large-scale production of brain-computer interface products [6] Group 4: Market Opportunities and Stock Performance - The brain-computer interface market is projected to grow significantly, with estimates of reaching 2.62 billion USD in 2024 and 2.94 billion USD in 2025 [7] - Stocks related to brain-computer interfaces have seen substantial price increases, with several companies experiencing over 100% growth this year [7][8] - Multiple companies in the sector have received institutional research attention, indicating strong investor interest and potential for future growth [8][9]

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00382 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 1,500,000,000 | USD | | 0.01 USD | | 15,000,000 | | 增加 / 減少 (-) | | | | | | USD | | | | 本月底結存 | | | 1,500,000,000 | USD | | 0.01 USD | | 15,000,000 | 本月底法定/註冊股本總額： USD 15,000,000 第 1 頁 共 10 頁 v 1.1.1 FF301 II. 已發行股份及/或庫存 ...

Edvantage Group Holdings Limited 中滙集團控股有限公司 (Incorporated in the Cayman Islands with limited liability) （於開曼群島註冊成立的有限公司） THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION 此乃重要文件 謹請立即處理 If you are in any doubt as to any aspect of this Election Form or as to the action to be taken, you should consult your licensed securities dealer or registered institution in securities, bank manager, solicitor, certified public accountant or other professional adviser. 閣下如對本選擇表格任何方面或應採取之行動有任何疑問 ，應諮詢 閣下之持牌證券交易 ...

此乃要件 請即處理 閣下如對本通函任何方面有任何疑問，應諮詢 閣下之股票經紀或其他註冊證券交易商、 銀行經理、律師、專業會計師或其他專業顧問。 閣下如已將名下之中滙集團控股有限公司之股份全部售出或轉讓，應立即將本通函連同隨 本通函附奉之選擇表格（如適用）送交買主或承讓人，或經手買賣或轉讓之銀行、股票經紀 或其他代理商，以便轉交買主或承讓人。 香港交易及結算所有限公司及香港聯合交易所有限公司對本通函的內容概不負責，對其準 確性或完整性亦不發表任何聲明，並表明概不就因本通函全部或任何部分內容而產生或因 依賴該等內容而引致的任何損失承擔任何責任。 任何境外股東如在香港以外任何司法權區收到本通函及╱或選擇表格，概不可視之為參與 以股代息計劃之邀約，除非本公司可在毋須遵照有關司法權區之任何登記或其他規定或手 續的情況下合法向其作出有關邀約。任何境外股東如欲就中期股息收取代息股份，其須自 行承擔責任，遵守一切任何有關司法權區之法律規定，包括獲得任何政府或其他同意或遵 守任何規定及辦理所需手續。 Edvantage Group Holdings Limited 中滙集團控股有限公司 （於開曼群島註冊成立的有限公司） （股份 ...